Drawing for SEVEN VAMPIRES

USPTO serial 97322835

SEVEN VAMPIRES

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
UKAOMA, ULOMA JANET
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SEVEN VAMPIRES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Brian W. Chellgren

Brian W. Chellgren DENTONS BINGHAM GREENEBAUM LLP300 WEST VINE STREET, SUITE 1300LEXINGTON, KY 40507United States

Goods and services

ClassDescriptionStatusFirst use
028Board games; card games; tabletop games; equipment sold as a unit for playing board games; equipment sold as a unit for playing card games; equipment sold as a unit for playing tabletop gamesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 11, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 11, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 12, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2024EX2GSOU EXTENSION 2 GRANTED—
Apr 11, 2024EXT2SOU EXTENSION 2 FILED—
Apr 11, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 11, 2023EX1GSOU EXTENSION 1 GRANTED—
Oct 11, 2023EXT1SOU EXTENSION 1 FILED—
Oct 11, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 14, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 14, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 25, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 10, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 31, 2022DOCKASSIGNED TO EXAMINER—
Mar 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 24, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance